To study the mechanism by which chloramphenicol inhibits bacterial protein synthesis, we examined the kinetics of the puromycin-induced release of peptides from transfer ribonucleic acid (tRNA) in the presence and in the absence of chloramphenicol. Washed Escherichia coli ribosomes with nascent peptides which had been radioactively labeled in vivo were used for this study. When such ribosomes were incubated in the presence of 10 jug of puromycin per ml, approximately onefourth of the radioactive peptide material was rapidly released from tRNA. This rapid, puromycin-dependent reaction is assumed to be equivalent to the peptidyl transferase reaction. Chloramphenicol inhibited the extent of the puromycininduced release of peptides by only 50%, demonstrating that some of the peptide chains which are present on active ribosomes react with puromycin, even in the presence of chloramphenicol. The addition of the supernatant fraction and guanosine triphosphate (GTP) increased the extent of the puromycin-induced release; this additional release was completely inhibited by chloramphenicol. Peptidyl chains on washed ribosomes prepared from chloramphenicol-inhibited cells were not released by puromycin in the presence of chloramphenicol and reacted slowly with puromycin in the absence of chloramphenicol. The release of peptidyl groups from these ribosomes became largely insensitive to chloramphenicol after preincubation of the ribosomes with GTP and the supernatant fraction. We conclude that chloramphenicol does not inhibit the peptidyl transferase reaction as measured by the puromycininduced release of peptides from tRNA, but rather inhibits some step in the peptide synthesis cycle prior to this reaction.
To study the mechanism by which chloramphenicol inhibits bacterial protein synthesis, we examined the kinetics of the puromycin-induced release of peptides from transfer ribonucleic acid (tRNA) in the presence and in the absence of chloramphenicol. Washed Escherichia coli ribosomes with nascent peptides which had been radioactively labeled in vivo were used for this study. When such ribosomes were incubated in the presence of 10 jug of puromycin per ml, approximately onefourth of the radioactive peptide material was rapidly released from tRNA. This rapid, puromycin-dependent reaction is assumed to be equivalent to the peptidyl transferase reaction. Chloramphenicol inhibited the extent of the puromycininduced release of peptides by only 50%, demonstrating that some of the peptide chains which are present on active ribosomes react with puromycin, even in the presence of chloramphenicol. The addition of the supernatant fraction and guanosine triphosphate (GTP) increased the extent of the puromycin-induced release; this additional release was completely inhibited by chloramphenicol. Peptidyl chains on washed ribosomes prepared from chloramphenicol-inhibited cells were not released by puromycin in the presence of chloramphenicol and reacted slowly with puromycin in the absence of chloramphenicol. The release of peptidyl groups from these ribosomes became largely insensitive to chloramphenicol after preincubation of the ribosomes with GTP and the supernatant fraction. We conclude that chloramphenicol does not inhibit the peptidyl transferase reaction as measured by the puromycininduced release of peptides from tRNA, but rather inhibits some step in the peptide synthesis cycle prior to this reaction.
Chloramphenicol (CAP) has been shown to inhibit protein synthesis in bacteria by interfering with some step involved in the growth of polypeptide chains on ribosomes (2, 22) . The only step which has been ruled out as the site of action of CAP is the codon-specific binding of transfer ribonucleic acid (tRNA) to ribosomes (20, 23) .
The synthesis of protein is generally believed to proceed on ribosomes by a cyclic process which involves the sequential additon of specific amino acyl tRNA to growing polypeptidyl chains (5, 10) . It is known that ribosomes, guanosine triphosphate (GTP), and supematant protein are required for this process, but the details of the individual steps involved in the synthesis of peptide bonds have not been established (5, 10, 19) .
Peptidyl tRNA remains associated with ribosomes which are isolated from Escherichia coli (3) . Under the appropriate conditions, these I Present address: Department of Molecular Biology and Virus Laboratory, University of California, Berkeley, Calif. 94720. peptidyl groups are transferred to puromycin in a reaction which has been called the peptidyl transferase reaction and which is thought to represent the terminal step in the cycle of reactions involved in peptide bond synthesis (10, 11, 24) . The peptidyl transferase is an integral part of the 50S ribosome (9) . In the absence of supernatant fraction and GTP, only a fraction of the peptidyl groups are transferred from tRNA on the ribosome to puromycin; in the presence of supernatant fraction and GTP, more peptides are transferred to puromycin (19) . These observations have been interpreted to mean that, in the peptide synthesis cycle, peptidyl tRNA exists sequentially in at least two states. In one, the "donpr" state, peptidyl tRNA is transferred to puromycin without additional factors; in the second, the "receptor" state, supematant fraction and GTP are required to move the peptidyl tRNA into the donor state before reaction with puromycin can occur (5, 10, 19) . Whether this interpretation is correct in detail is open to question. However, the reaction of peptidyl tRNA with puromycin in the absence of supernatant fraction and GTP can be assumed to represent the peptidyl transferase reaction and can be used to test whether CAP inhibits this reaction or some prior reaction in the peptide bond synthesizing cycle.
With puromycin, it is possible to test only for the reactivity of peptidyl tRNA, not for its physical position on the ribosome. For this reason, we refer to the donor state rather than the donor site.
We used preparations of ribosomes with nascent peptides radioactively labeled in vivo. Such preparations should contain ribosomes in each of the normal intermediate states of peptide bond synthesis. From a kinetic analysis of the puromycin-induced release of peptides from tRNA in the presence and in the absence of CAP, we conclude that CAP does not directly inhibit the peptidyl transferase reaction but rather inhibits some prior step in the peptide bond synthesizing cycle.
MATERIALS AND METHODS
Bacterial culture conditions. Cultures of Escherichia coli K-12 were grown by forced aeration at 33 C in a minimal salts medium (17) with 0.2% glucose. Growth was followed with a Klett-Summerson Colorimeter at 540 nm.
Preparation of ribosomes with labeled nascent peptides. A 700-ml culture of bacteria was grown to 1.1 X 109 bacteria/ml and 25 uc of 3H-leucine (New England Nuclear Corp., Boston, Mass.) was added at a specific activity of 0.1 mc/;Lmole for 10 to 20 sec.
The culture was then poured over crushed ice and the cells were collected by centrifugation. For experiments with ribosomes from CAP-inhibited cells, the isotope was added for 10 sec; CAP, at a final concentration of 100 4g/ml, was added for an additional 10 sec; the culture was then poured over ice and harvested by centrifugation. Cells were suspended in 10 ml of cold TMN buffer (0.01 M tris(hydroxymethyl)aminomethane, 0.01 M Mg acetate, 0.16 M NH4Cl, pH 7.4) with 5 jAg of deoxyribonuclease per nil and broken in a chilled French pressure cell at 18,000 lb/inch2. The ribosomes were prepared either by a single centrifugation (13) or by repeated centrifugation in high salt (14) with little difference in the results obtained. Ribosomes from CAP-treated cells were washed with buffer containing CAP but were suspended without CAP. Ribosomes were quick-frozen and stored at -60 C at a concentration of approximately 2 mg/ml. Preparation of supernatant fraction. Supernatant fraction (S-105) was prepared as described by Nirenberg (13), except that 0.16 M NH4Cl replaced potassium. The S-105 fraction was used in all cases with GTP, an adenosine triphosphate generating system, and mercaptoethanol, as described by Nirenberg (13) but without polyuridylic acid or additional amino acids.
Assays for the puromycin reaction. Diethylaminoethyl (DEAE) paper assay measures the release of peptides from tRNA and takes advantage of the fact that, at pH 1.9, RNA will bind to DEAE, whereas proteins can be washed off (6) . A suspension of ribosomes with labeled nascent peptides was centrifuged at 30,000 X g for 1 hr to remove aggregated material. It was then diluted approximately fivefold with TMN buffer, incubated under the appropriate conditions, and at various times 300-;liter samples were removed and added to 5 ml of pH 1.9 buffer (8.7% acetic acid, 2.5% formic acid). The samples were then applied without suction to 22-mm circles punched from sheets of DEAE paper (Whatman DE 81) supported on a filtering apparatus (Tracerlab). The circles had been thoroughly soaked beforehand in pH 1.9 buffer and were used at double thickness. The sample tubes were rinsed with pH 1.9 buffer, the rinses were applied to the filters, and the filters were each washed three times with 5 ml of 8 M urea, in pH 1.9 buffer, twice more with pH 1.9 buffer, and three times with acetone. The filters were dried in an oven and counted in 10 ml of a toluene-based scintillation fluid, using a Beckman liquid scintillation counter. Radioactive peptides attached to tRNA should be retained by the filter and peptides not attached to tRNA should wash through.
Controls indicate that the procedure does indeed separate free peptides from peptidyl tRNA since, under our conditions, the filters retained over 90% of the radioactivity in a "4C-aminoacyl tRNA solution, but less than 1% of the supernatant protein and less than 10% of the radioactivity in a suspension of ribosomes labeled with 14C-arginine.
This method has been used to determine the kinetics of the puromycin reaction since addition of pH 1.9 buffer stops the reaction, the assay is rapid, and large numbers of samples can be handled conveniently. However, since peptidyl tRNA from damaged and unreactive ribosomes will be retained by the filter, the background is quite high. Moreover, there seems to be a great deal of variability in the DEAE paper itself and the paper tears easily when wet. Therefore, it is wise to run samples in duplicate when possible. In addition, excessive heating generates a chemiluminescence in the DEAE paper which increases the apparent background, so that drying at a relatively low temperature (110 C) is desirable.
Sucrose density gradient analysis measures the release of nascent peptides from ribosomes. A solution of ribosomes was incubated in a total volume of 0.5 ml at 30 C for 15 min, with or without supernatant fraction and GTP. The sample was then chilled, and an 0.45-ml amount was layered on a 5 to 20% linear sucrose density gradient in TMN buffer and centrifuged at 37,000 rev/min for 2 hr in a Spinco model L. Eight-drop fractions were collected directly into 10 ml of a dioxane-based scintillation fluid. The radioactivity in the region of the 70S ribosomes was then determined and summed. This method cannot be used to determine kinetics since chilling does not stop the puromycin reaction; per cent release determined in this way represents an end point. 
RESULTS
Kinetics of the puromycin reaction. In attempting to make use of the puromycin reaction to study the mechanism of CAP action, we discovered that there are several reactions which could release peptides from ribosome-bound peptidyl tRNA and that it was necessary to distinguish carefully between them. The kinetics of release of peptides from tRNA at various concentrations of puromycin are shown in Fig. 1 . There is a slow release in the absence of puromycin, but in the presence of puromycin there is, in addition, an initial rapid release, the kinetics of which are dependent on the concentration of puromycin (10) . We assume this rapid release to be equivalent to the peptidyl transferase reaction. Two anomalous characteristics of the puromycin reaction were seen. First, the extent of the release of peptides from tRNA during the initial rapid phase increased with increasing amounts of puromycin. Second, the extent of the reaction at 250 ,ug of puromycin per ml was disproportionately greater than at lower concentrations. These results would not be obtained if increasing amounts of puromycin were simply saturating the peptidyl transferase reaction. Therefore, we believe these are indications of an alternative reaction dependent on high levels of puromycin. To minimize this problem, we used a concentration of 10 ,ug of puromycin per ml in our experiments. At this concentration, the initial puromycin reaction was complete in 15 min.
The slow puromycin-independent release of peptides from tRNA does not compete with the puromycin reaction, as shown by the following experiment. A suspension of ribosomes with labeled nascent peptide chains was incubated for 5 hr under the conditions given in Table 1 . The release of peptide groups from tRNA was assessed in the presence and absence of puromycin at 0-time and after 5 hr ( Table 1 ). The total counts released by puromycin were the same, showing that the puromycin-independent release of peptides does not cause the loss of peptides which participate in the puromycin reaction.
The slow puromycin-independent reaction takes place both at 4 C and at 30 C. In addition, there is another puromycin-independent reaction (not shown) which takes place when the ribosomes are warmed from 4 to 30 C and which goes to completion in 15 min. This reaction can constitute a loss of peptides from tRNA of as much as 30%. However, it also does not compete with the puromycin reaction which will proceed as well after the ribosomes have been warmed to Thus, there are at least three types of release of peptide from tRNA in this system: the puromycin reaction itself and the two puromycinindependent reactions. All three types of release were seen in approximately the same proportions with frozen and with unfrozen ribosomes which had been washed once and with frozen ribosomes washed by the more extensive procedure of Nishizuka and Lipmann (14) . So as not to be misled by the puromycin-independent reactions, all control tubes without puromycin were treated exactly as were the experimental tubes.
CAP-resistant component of the puromycin reaction. If CAP inhibits protein synthesis at a step before peptidyl transfer, then ribosomes with attached nascent chains labeled in vivo should exist in two distinct states: (i) CAPresistant, in which the peptidyl tRNA is in the donor state ready to react with puromycin; (ii) CAP-sensitive, in which the peptidyl tRNA has first to be converted into the donor state before reaction with puromycin can take place. CAP would then be expected to inhibit the extent of the puromycin reaction. On the other hand, if CAP directly blocks the peptidyl transferase reaction, then peptide bond formation on all the ribosomes should be equally sensitive to CAP and CAP would be expected to inhibit only the rate of the puromycin reaction. As shown in Fig.  2 Fig. 1 , except that puromycin was 10 pg/ml and CAP was 100 pg/ml. Symbols: (X) minus puromycin; (0) plus CAP, plus puromycin; (@) minus CAP, plus puromycin.
varying the concentration of CAP from 20 ,ug/ml to 500 ,ug/ml. However, CAP sensitivity could be largely overcome by raising the puromycin concentration five-fold. This could be due either to a competition between the two antibiotics (e.g., for binding sites; reference 20) or to an alternative reaction between puromycin and peptidyl tRNA which would ordinarily be unreactive. In either case, the use of low levels of puromycin minimizes this difficulty. We interpret the data in Fig. 2 to mean that peptidyl tRNA can exist in a state where it is available for peptide bond formation even in the presence of CAP.
Traut and Monro (19) demonstrated that addition of supernatant enzymes and GTP could increase the extent of the puromycin reaction and concluded that the supernatantdependent steps are necessary for conversion of peptidyl tRNA from the receptor to the donor state. We therefore expected that the supematant-dependent fraction of the puromycin reaction would be completely inhibited by CAP. The data in Table 2 demonstrate that this is the case. The extent of the puromycin reaction could be increased from 51 to 72% release by the addition of GTP and supernatant fraction. In the presence of CAP, however, the puromycin reaction proceeded to the same extent regardless of the presence of GTP and supernatant fraction. This indicates that the component of the puromycin reaction which is dependent on the addition of GTP and supernatant fraction was completely blocked by the prior addition of CAP and suggests that it is some step in the conversion of Fig. 2 . The ribosomes had been stored at -60 C for I day. After storage in the freezer for more than a few days, ribosomes.from CAP-treated cells behaved like ribosomes from exponentially growing cells and were not especially sensitive to CAP. Storage in liquid nitrogen or in 50% glycerol did not preserve their CAP sensitivity. Symbols: (X) minus puromycin; (0) plus CAP, plus puromycin; (0) minus CAP, plus puromycin. Table 2 . b Preincubated for 5 min at 30 C with supernatant fraction and GTP before addition of CAP and puromycin. complete in 15 min (see Fig. 2 ). These data suggest that ribosomes from CAP-inhibited cells have accumulated peptidyl tRNA in a state other than the donor state.
Ribosomes from CAP-treated cells are not permanently unreactive, but can be partially reactivated by the addition of supernatant fraction and an energy source (Table 3) . Moreover, this reactivation is highly sensitive to CAP if CAP is added first. However, if supernatant fraction and an energy source are incubated with the ribosomes for 5 min at 30 C before the addition of CAP then CAP, becomes a less effective inhibitor of the puromycin reaction. These results thus support our conclusion that CAP does not act by directly inhibiting the transfer of a peptide to puromycin but blocks a step prior to the formation of this peptide bond. DISCUSSION On the basis of our data, we have concluded that CAP does not directly block the peptidyl transferase reaction in protein synthesis but rather inhibits in some way the conversion of peptidyl tRNA into the puromycin-susceptible donor state. Such an interpretation is consistent with the observation that CAP causes the accumulation of dipeptides and inhibits the synthesis of longer chains in an in vitro system with polyadenylic acid as message (7) and is relatively ineffective in inhibiting "endogenous" incorporation in vitro (8) . In both cases, a high proportion of amino acid incorporation may be due to the formation of a single peptide bond per ribosome, the ribosomes which are active in the presence of CAP being those with peptidyl tRNA in the reactive donor state. In addition, Gottesman (4) recently demonstrated that the addition of a single lysine residue to a polylysine chain is insensitive to CAP, providing clear evidence that peptidyl transfer can occur in the presence of CAP.
Another line of evidence consistent with our conclusion is the previously unexplained finding that amino acid incorporation in vitro is highly variable in its sensitivity to CAP, depending on the particular messenger RNA used (8, 16) . In general, incorporation directed by synthetic polynucleotides is quite insensitive to CAP, the degree of sensitivity in the case of the homopolymers varying inversely with the ability of the polynucleotide to stimulate incorporation, whereas amino acid incorporation directed by "natural" message is generally quite sensitive to CAP. This suggests that, in the case of synthetic messenger-directed incorporation, cycles of peptide bond formation are occurring which bypass the CAP-sensitive step. However, the peptidyl transfer reaction is the one step in the peptide bond-synthesizing cycle which cannot be bypassed. This is because peptidyl transfer is the only step which is actually being assayed when one measures an increase in acid-precipitable radioactivity. Therefore, we feel it is unlikely that peptidyl transfer could be the step which is CAP-sensitive. Of course, in suggesting that CAP-resistant amino acid incorporation is due to a bypassing of the CAP-sensitive step, we assume that the steps in protein synthesis can become "uncoupled" from one another. That such an uncoupling of the steps in protein synthesis might occur has been shown by Smith (15) , who demonstrated that heptaadenylic acid can direct the synthesis of tri-and tetralysine and by Thach et al. (18) who obtained equivalent results with block copolymers. This "reiterative" polypeptide synthesis requires an uncoupling of ribosome movement from the other steps in chain growth. Therefore, we suggest that the ability of a synthetic polynucleotide to promote CAP-resistant amino acid incorporation is dependent on its ability to promote cycles of peptide bond formation in which the steps are uncoupled. This would allow peptidyl transfer to occur in spite of the CAP inhibition of one of the other steps. In this way, the puzzling reports that the CAP sensitivity of in vitro systems varies with the messenger RNA can be explained in a manner consistent with our hypothesis that CAP does not inhibit the peptidyl transfer reaction directly but rather inhibits some prior step in the peptide bond-synthesizing cycle.
From the following considerations, it seems likely that CAP, although acting before the peptidyl transferase reaction, acts after the GTP and supematant fraction-dependent steps. (i) Extensive washing of the ribosomes (which should free them of supernatant factors) does not abolish their sensitivity to CAP, indicating that the CAP-sensitive step can take place in the absence of supematant fraction and GTP. (ii) Inhibitors of the GTP-dependent step seem not to inhibit the CAP-sensitive step, since these inhibitors (mercurials, lithium ion, GDP, and guanylyl methylene diphosphonate) do not inhibit the puromycin reaction with washed ribosomes (10, 19 ; unpublished data), whereas CAP does. Although other explanations are possible (10), it seems likely from this work that ribosomebound peptidyl tRNA can exist in a state where it has become independent of GTP but is still sensitive to CAP.
Therefore, we feel that, although there may be only two tRNA binding sites on a ribosome (21) , there are at least three states in which peptidyl tRNA on a ribosome can exist. In these states, reaction with puromycin is (i) dependent on GTP and supernatant fraction and sensitive to CAP, (ii) independent of GTP and supernatant fraction and sensitive to CAP, or (iii) independent of GTP and supernatant fraction and resistant to CAP. Peptidyl tRNA in state iii is presumably in the reactive donor state, but the relation of the other two states to the proposed mechanisms of protein synthesis is obscure, since little is understood about the function of GTP and supernatant factors in amino acid polymerization.
Thus, although we have shown that CAP does not directly inhibit peptidyl transfer, the precise nature of the CAP-sensitive step is still unknown. CAP might directly inhibit the "translocase" (19) which moves peptidyl tRNA from the receptor to the donor site, or it might inhibit the movement of the ribosome along the message, the expelling of discharged tRNA from the donor site, or some as yet unknown reaction. There is insufficient evidence available to warrant a choice between these alternatives.
